These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 20808988
1. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging. Ozülker T, Ozülker F, Ozpaçaci T, Bender O, Değirmenci H. Hell J Nucl Med; 2010; 13(2):144-9. PubMed ID: 20808988 [Abstract] [Full Text] [Related]
2. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography. Gommans GM, van der Zant FM, van Dongen A, Boer RO, Teule GJ, de Waard JW. Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524 [Abstract] [Full Text] [Related]
3. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions. Ambrus E, Rajtár M, Ormándi K, Séra T, Tószegi A, Láng J, Pávics L, Csernay L. Anticancer Res; 1997 Feb; 17(3B):1599-605. PubMed ID: 9179201 [Abstract] [Full Text] [Related]
4. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report. Arslan N, Ozturk E, Ilgan S, Narin Y, Dundar S, Tufan T, Pekcan M, Bayhan H. Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579 [Abstract] [Full Text] [Related]
5. Using Tc-99m MIBI scintimammography to differentiate nodular lesions in breast and detect axillary lymph node metastases from breast cancer. Chen J, Wu H, Zhou J, Hu J. Chin Med J (Engl); 2003 Apr; 116(4):620-4. PubMed ID: 12875735 [Abstract] [Full Text] [Related]
6. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742 [Abstract] [Full Text] [Related]
7. Technetium-99m-MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement. Myslivecek M, Koranda P, Kamínek M, Husák V, Hartlová M, Dusková M, Cwiertka K. Nucl Med Rev Cent East Eur; 2004 Jan; 7(2):151-5. PubMed ID: 15968602 [Abstract] [Full Text] [Related]
8. Diagnostic accuracy of Tc-99m-MIBI for breast carcinoma in correlation with mammography and sonography. Habib S, Maseeh-uz-Zaman, Hameed A, Niaz K, Hashmi H, Kamal S. J Coll Physicians Surg Pak; 2009 Oct; 19(10):622-6. PubMed ID: 19811712 [Abstract] [Full Text] [Related]
9. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women. Sun SS, Hsieh JF, Tsai SC, Ho YJ, Lee JK, Kao CH. Anticancer Res; 2000 Oct; 20(3B):2133-6. PubMed ID: 10928166 [Abstract] [Full Text] [Related]
10. 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis. Arslan N, Oztürk E, Ilgan S, Urhan M, Karaçalioglu O, Pekcan M, Tufan T, Bayhan H. Nucl Med Commun; 1999 Apr; 20(4):317-25. PubMed ID: 10319351 [Abstract] [Full Text] [Related]
11. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI. Papantoniou V, Christodoulidou J, Papadaki E, Valotassiou V, Stipsanelli A, Louvrou A, Lazaris D, Sotiropoulou M, Pampouras G, Keramopoulos A, Michalas S, Zerva C. Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092 [Abstract] [Full Text] [Related]
12. Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer. Palmedo H, Schomburg A, Grünwald F, Mallmann P, Boldt I, Biersack HJ. Nucl Med Biol; 1996 Aug; 23(6):681-4. PubMed ID: 8940710 [Abstract] [Full Text] [Related]
13. Is (99m)Tc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses? Alonso O, Massardo T, Delgado LB, Horvath J, Kabasakal L, Llamas-Olier A, Maunda KK, Morales R, Padhy AK, Shankar UR. J Nucl Med; 2001 Nov; 42(11):1614-21. PubMed ID: 11696629 [Abstract] [Full Text] [Related]
14. [Scintimammography with 99mTC-MIBI in the clinical practice: repercussion on the clinical management of the patient]. Prats E, Razola P, Sainz JM, Tardín L, Andrés A, Abós MD, García F, Fernández J, Villavieja L, Banzo J. Rev Esp Med Nucl; 2007 Nov; 26(3):153-9. PubMed ID: 17524309 [Abstract] [Full Text] [Related]
15. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions. Fenlon HM, Phelan N, Tierney S, Gorey T, Ennis JT. Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430 [Abstract] [Full Text] [Related]
16. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI. Akçay MN, Akin Y, Karabağ B, Ozcan O, Oren D. Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644 [Abstract] [Full Text] [Related]
17. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer. Taillefer R, Robidoux A, Turpin S, Lambert R, Cantin J, Léveillé J. J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292 [Abstract] [Full Text] [Related]
18. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer. Kim SJ, Kim IJ, Bae YT, Kim YK, Kim DS. Eur J Radiol; 2005 Feb; 53(2):192-8. PubMed ID: 15664282 [Abstract] [Full Text] [Related]
19. Scintimammography using Tc-99m tetrofosmin. Lind P, Umschaden HW, Forsthuber E, Oman J, Kerschbaumer K, Gallowitsch HJ, Mikosch P, Kresnik E, Molnar M, Gomez I. Acta Med Austriaca; 1997 Feb; 24(2):50-4. PubMed ID: 9227787 [Abstract] [Full Text] [Related]
20. Tc-99m MIBI in suspected recurrent breast cancer. Cwikla JB, Kolasinska A, Buscombe JR, Hilson AJ. Cancer Biother Radiopharm; 2000 Aug; 15(4):367-72. PubMed ID: 11041021 [Abstract] [Full Text] [Related] Page: [Next] [New Search]